{
    "2021-04-06": [
        [
            {
                "time": "2021-04-06",
                "original_text": "Wind医药：每日行业动态（2021-04-06）",
                "features": {
                    "keywords": [
                        "医药",
                        "动态",
                        "Wind"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "贝达药业BPI-16350药品联用临床试验申请获受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "BPI-16350",
                        "临床试验",
                        "受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "贝达药业(300558.SZ)：BPI-16350药品联用临床试验申请获得受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "300558.SZ",
                        "BPI-16350",
                        "临床试验",
                        "受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04",
                "original_text": "医药行业2021年4月投资月报：把握一季报最佳反弹窗口期 加配低估值且高增长标的",
                "features": {
                    "keywords": [
                        "医药",
                        "投资",
                        "一季报",
                        "反弹",
                        "低估值",
                        "高增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04",
                "original_text": "医药行业周报：当前是反弹最佳窗口期 加配低估值高增长标的",
                "features": {
                    "keywords": [
                        "医药",
                        "反弹",
                        "低估值",
                        "高增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04",
                "original_text": "医药生物行业：为什么说智飞生物二季度有望迎来亮眼表现？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "智飞生物",
                        "二季度",
                        "亮眼表现"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}